For the Inventor, By the Inventor

Enter assignee name

Thousand Oaks, CA, United States of America

Amgen Inc.

Calculating rank

USPTO Granted Patents = 2,076

% Expired Patents = 19.0

CIPO Patents = 53

EPO Patents = 675

Trademarks = 76

Forward Citations = 25,396

Loading Chart...

Loading Chart...

2,430 inventors (with patents filed for the assignee):

Ning Chen (56 out of 56 patents)

Scott Robert Gibson (55 out of 91 patents)

Thomas Charles Boone (54 out of 55 patents)

4. Jennifer Rebecca Allen (49 out of 50 patents)

5. Mark Henry Norman (46 out of 51 patents)

6. Patricia Lopez (45 out of 45 patents)

7. Jonathan B Houze (45 out of 56 patents)

8. Andrew Stewart Tasker (43 out of 67 patents)

9. Thomas T Nguyen (41 out of 44 patents)

10. Qingyian Liu (41 out of 41 patents)

11. Nobuko Nishimura (40 out of 40 patents)

12. Matthew R Kaller (40 out of 40 patents)

13. Julio Cesar Medina (40 out of 73 patents)

14. Chadwick Terence King (39 out of 59 patents)

15. Jian Jeffrey Chen (39 out of 64 patents)

Core Competencies:

Drug Delivery Device

Automated Visual Inspection

Cancer Treatment

Antibody Constructs

T Cell Engaging

KRAS G12C Inhibitors

Cell Culture Method

Protein Stability

Biomarkers

Quality Evaluation

Pharmaceutical Composition

Syringe Assembly

2,076 patents: Sort by Forward Citations

1. D1155795 - Wearable drug delivery device (2026-10-27),

2. 12774330 - Continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes (2026-10-27),

3. 12770328 - 3D particle imaging in pharmaceutical containers (2026-10-20),

4. 12766252 - Drug delivery device with sterile fluid flowpath and related method of assembly (2026-10-20),

5. 12760262 - In-process verification of calibration status of pH probes (2026-10-13),

6. 12760057 - PURIFICATION METHODS FOR CARBOHYDRATE-LINKED OLIGONUCLEOTIDES (2026-10-13),

7. 12758612 - GROWTH DIFFERENTIATION FACTOR 15 COMBINATION THERAPY (2026-10-13),

8. 12746343 - Delivery devices for administering drugs (2026-09-29),

9. 12746334 - Drug delivery device having removable cap (2026-09-29),

10. 12742169 - RNAi CONSTRUCTS AND METHODS FOR INHIBITING LPA EXPRESSION (2026-09-22),

11. 12741977 - Methylation of Mcl-1 compounds (2026-09-22),

12. 12737927 - Image augmentation techniques for automated visual inspection (2026-09-15),

13. 12737891 - Imaging-based system for monitoring quality of cells in culture (2026-09-15),

14. 12735419 - Process for racemizing and isolating atropisomers of 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-D]pyrimidine-2,4(1H,3H)-dione (2026-09-15),

15. 12734305 - Drug delivery device assembly and accessory for drug delivery device (2026-09-15),

Company Overview

Amgen Inc., headquartered in Thousand Oaks, California, is a leading biotechnology company specializing in the development and manufacturing of innovative drug delivery devices. The organization focuses on advanced therapeutic solutions, particularly in cancer treatment, utilizing technologies such as antibody constructs and T cell engaging therapies. Amgen is also engaged in enhancing drug delivery through automated visual inspection and optimizing cell culture methods to improve protein stability, contributing significantly to the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

2,076 Patents

#1 in Thousand Oaks, CA

#63 in California

#249 in US

#488 in the World

Thousand Oaks, CA, United States of America

Amgen Inc.

Forward Citations = 25,396

2,430 inventors:

Ning Chen (56 out of 56 patents)

Scott Robert Gibson (55 out of 91 patents)

Thomas Charles Boone (54 out of 55 patents)

4. Jennifer Rebecca Allen (49 out of 50 patents)

5. Mark Henry Norman (46 out of 51 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amgen Inc.. Retrieved from https://idiyas.com/company/amgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…